Verified ProfileEN

TIANJIN HEZHI PHARMACEUTICAL GROUP CO.,LTD.

Order verification — $199

Manufacturing · Chinese Patent Medicine Manufacturing

Verification dossier

TIANJIN HEZHI PHARMACEUTICAL GROUP CO.,LTD. is a Chinese company based in Tianjin. The company operates in the chinese patent medicine manufacturing sector, within the broader manufacturing industry. Established 2002, the company has been operating for 24 years.

Sinolinks tracks TIANJIN HEZHI PHARMACEUTICAL GROUP CO.,LTD. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Licensed items: Drug production; drug wholesale; contract drug manufacturing; drug import and export; drug online information services; food production; health food production; production of sanitary products and disposable medical supplies; road freight transport (excluding dangerous goods); production of Class III medical devices. General items: Food sales (prepackaged foods only); sales of health foods (prepackaged); sales of personal hygiene products; sales of sanitary products and disposable medical supplies; manufacture of sports goods and equipment; import and export of goods; technology services, development, consulting, exchange, transfer, promotion; production of Class I...

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review